Literature DB >> 35593650

VEGF-A controls the expression of its regulator of angiogenic functions, dopamine D2 receptor, on endothelial cells.

Chandrani Sarkar1,2,3,4,5, Debanjan Chakroborty1,2,3,4,5, Sandeep Goswami1,3,4, Hao Fan1, Xiaokui Mo6, Sujit Basu1,2,7.   

Abstract

We have previously demonstrated significant upregulation of dopamine D2 (DAD2) receptor (DRD2) expression on tumor endothelial cells. The dopamine D2 receptors, upon activation, inhibit the proangiogenic actions of vascular endothelial growth factor-A (VEGF-A, also known as vascular permeability factor). Interestingly, unlike tumor endothelial cells, normal endothelial cells exhibit very low to no expression of dopamine D2 receptors. Here, for the first time, we demonstrate that through paracrine signaling, VEGF-A can control the expression of dopamine D2 receptors on endothelial cells via Krüppel-like factor 11 (KLF11)-extracellular signal-regulated kinase (ERK) 1/2 pathway. These results thus reveal a novel bidirectional communication between VEGF-A and DAD2 receptors.
© 2022. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Dopamine D2 receptor; Endothelial cell; VEGF-A

Mesh:

Substances:

Year:  2022        PMID: 35593650      PMCID: PMC9234670          DOI: 10.1242/jcs.259617

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.235


  45 in total

1.  The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.

Authors:  S Basu; J A Nagy; S Pal; E Vasile; I A Eckelhoefer; V S Bliss; E J Manseau; P S Dasgupta; H F Dvorak; D Mukhopadhyay
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

Review 2.  VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis.

Authors:  Janice A Nagy; Ann M Dvorak; Harold F Dvorak
Journal:  Trends Cardiovasc Med       Date:  2003-07       Impact factor: 6.677

3.  Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition.

Authors:  Yi Zhang; Md Nasrul Hoda; Xuan Zheng; Weiguo Li; Pengcheng Luo; Krishna Rao Maddipati; Tsugio Seki; Adviye Ergul; Mong-Heng Wang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-02       Impact factor: 3.619

4.  Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis.

Authors:  Sujit Basu; Chandrani Sarkar; Debanjan Chakroborty; Janice Nagy; Rita Basu Mitra; Partha Sarathi Dasgupta; Debabrata Mukhopadhyay
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

Review 5.  Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook.

Authors:  Josep Garcia; Herbert I Hurwitz; Alan B Sandler; David Miles; Robert L Coleman; Regula Deurloo; Olivier L Chinot
Journal:  Cancer Treat Rev       Date:  2020-03-26       Impact factor: 12.111

6.  Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer.

Authors:  Kirsten L Bryant; Clint A Stalnecker; Daniel Zeitouni; Jennifer E Klomp; Sen Peng; Andrey P Tikunov; Venugopal Gunda; Mariaelena Pierobon; Andrew M Waters; Samuel D George; Garima Tomar; Björn Papke; G Aaron Hobbs; Liang Yan; Tikvah K Hayes; J Nathaniel Diehl; Gennifer D Goode; Nina V Chaika; Yingxue Wang; Guo-Fang Zhang; Agnieszka K Witkiewicz; Erik S Knudsen; Emanuel F Petricoin; Pankaj K Singh; Jeffrey M Macdonald; Nhan L Tran; Costas A Lyssiotis; Haoqiang Ying; Alec C Kimmelman; Adrienne D Cox; Channing J Der
Journal:  Nat Med       Date:  2019-03-04       Impact factor: 53.440

7.  Krüppel-like factor 11 differentially couples to histone acetyltransferase and histone methyltransferase chromatin remodeling pathways to transcriptionally regulate dopamine D2 receptor in neuronal cells.

Authors:  Seungmae Seo; Gwen Lomberk; Angela Mathison; Navtej Buttar; Jewel Podratz; Ezequiel Calvo; Juan Iovanna; Stephen Brimijoin; Anthony Windebank; Raul Urrutia
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

Review 8.  Mechanisms and regulation of endothelial VEGF receptor signalling.

Authors:  Michael Simons; Emma Gordon; Lena Claesson-Welsh
Journal:  Nat Rev Mol Cell Biol       Date:  2016-07-27       Impact factor: 94.444

9.  Probiotics ingestion prevents HDAC11-induced DEC205+ dendritic cell dysfunction in night shift nurses.

Authors:  Hui Yang; Jing Yang; Hui Cheng; Huili Cao; Shan Tang; Qiaohong Wang; Juan Zhao; Baohua Li; Yongxia Ding; Chang Ma
Journal:  Sci Rep       Date:  2019-11-29       Impact factor: 4.379

10.  A Reassessment of the Therapeutic Potential of a Dopamine Receptor 2 Agonist (D2-AG) in Endometriosis by Comparison against a Standardized Antiangiogenic Treatment.

Authors:  Miguel Á Tejada; Ana I Santos-Llamas; María José Fernández-Ramírez; Juan J Tarín; Antonio Cano; Raúl Gómez
Journal:  Biomedicines       Date:  2021-03-08
View more
  2 in total

1.  Neuropeptide Y, a paracrine factor secreted by cancer cells, is an independent regulator of angiogenesis in colon cancer.

Authors:  Debanjan Chakroborty; Sandeep Goswami; Hao Fan; Wendy L Frankel; Sujit Basu; Chandrani Sarkar
Journal:  Br J Cancer       Date:  2022-07-28       Impact factor: 9.075

2.  Endothelial KLF11 as a Nephroprotectant in AKI.

Authors:  Gelare Ghajar-Rahimi; Anupam Agarwal
Journal:  Kidney360       Date:  2022-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.